Chloe Yang
Impact in
- Endocrinology top 5%
- Vibrio bacteria research studies
-
- Autophagy in Disease and Therapy
Papers in
-
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 2
- Oncology 6
- CAR-T cell therapy research 3
- Cancer Treatment and Pharmacology 2
- Neutropenia and Cancer Infections 2
- Co-authors
- Matthew T. Sorbara (2 shared papers)Stephen E. Girardin (2 shared papers)Dana J. Philpott (2 shared papers)Ivan Tattoli (2 shared papers)Letícia A. M. Carneiro (1 shared paper)Arthur R. Ling (1 shared paper)Andrew Emili (1 shared paper)Dajana Vuckovic (1 shared paper)
- Journals
- Blood (10 papers)Antiviral Therapy (1 paper)Journal of the International AIDS Society (1 paper)Transgender Health (1 paper)Cell Host & Microbe (1 paper)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Chloe Yang
13 papers receiving 458 citations
Peers
Comparison fields: 5 of 72
- Endocrinology 107
- Epidemiology 185
- Immunology 113
- Physiology 23
- Biotechnology 32
Countries citing papers authored by Chloe Yang
This map shows the geographic impact of Chloe Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Yang more than expected).
Fields of papers citing papers by Chloe Yang
This network shows the impact of papers produced by Chloe Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Yang. The network helps show where Chloe Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chloe Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 304 | |
| 2 | 2013 | 104 | |
| 3 | 2021 | 29 | |
| 4 | 2015 | 10 | |
| 5 | 2017 | 5 | |
| 6 | 2014 | 3 | |
| 7 | 2022 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2024 | 0 | |
| 15 | 2023 | 0 | |
| 16 | 2024 | 0 | |
| 17 | 2019 | 0 | |
| 18 | 2023 | 0 | |
| 19 | 2026 | 0 | |
| 20 | 2025 | 0 |
About Chloe Yang
Chloe Yang is a scholar working on Hematology, Oncology, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 23 papers that have together received 465 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), CAR-T cell therapy research (3 papers), Cancer Treatment and Pharmacology (2 papers), HIV/AIDS drug development and treatment (2 papers), Cancer Mechanisms and Therapy (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Endocrinology (107 citations), Epidemiology (185 citations), Immunology (113 citations), Physiology (23 citations) and Biotechnology (32 citations). Chloe Yang has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Matthew T. Sorbara, Stephen E. Girardin, Dana J. Philpott, Ivan Tattoli, Letícia A. M. Carneiro, Arthur R. Ling, Andrew Emili, Dajana Vuckovic, Fraser Soares and Sharon A. Tooze. Their work appears in journals such as Blood, Antiviral Therapy, Journal of the International AIDS Society, Transgender Health and Cell Host & Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.